CD7 and neoplasm: Comparing the fluorescent staining of reactive CD4+ T cells (blue crosses) and malignant CD4+ T cells (red crosses) showed that in tumor cells CD7 was decreased and CD25 and Ki-67 were increased (Fig. 1g), consistent with an advanced CTCL phenotype26.